SlideShare a Scribd company logo
1 of 34
ITP
60-year-old female Presented in emergency
room with recent onset of easy bruising,
bleeding gums, and persistent epistaxis .She has
no personal or family history of a bleeding
disorder and takes no medicines.
Case scenario
History
Age: 60 year old
Gander: Female
Occupation: Don’t work
Personal
history
recent onset of easy bruising
bleeding gums
and persistent epistaxis
Chief complain
History
No constitutional symptoms
Constitutional
symptoms
Unremarkable
Systemic review
Unremarkable
Past surgical
history
No previous similar conditionPast history
No significant family history or bleeding
disorder were reported
Social and
family history
History
ITP
Physical examination
General
examination
Blood
pressure
Respiratory
rate
Heart rate
Temperature
Local examination
 easy bruising
 bleeding gums
 Persistent epistaxis
 Abdominal examination reveled no
hepatosplenomegaly
 No abdominal tenderness
Physical examination
Physical examination
Local examination
 Examination of the skin
Numerous petechiae and
purpura mostly on the extremities
 Joint were non tender and non erythematous
 The neurologic examination was normal
ITP
Differential diagnosis
Aplastic anemia
Acute leukemia
Idiopathic thrombocytopenia purpura
Myelodysplastic syndrome
Megaloblastic anemia
Von willebrand’s disease
Thrombotic thrombocytopenia purpura
ITP
1- CBC
2- Peripheral blood smear
3- Further investigations
- bone marrow biopsy
- coagulation
Investigation
1- CBC
 Aplastic anemia
(pancytopenia)
 Myelodysplastic syndrome
(pancytopenia and splenomegaly
)
 Von willebrand’s disease
(platelets count normal except
2B)
Investigation
FlagsReference rangeResultTest
N3.8 – 4.84.52 x 1012/LRBC
N12 – 1513.4 g/ dLHGB
Low38 – 4837.2 %HCT
low83 – 10182.3 FLMCV
N27 – 3229.6 pgMCH
High31.5 – 34.535.9 g/dLMCHC
N11.6 – 1412.1 %RDW
N4 – 115.3 x 109/LWBC
N2.5 – 7.52.3 x 109/LN
N1.5 – 3.52.1 x 109/LL
N0.2 – 0.80.7 x 109/LM
N0.04 – 0.40.1 x 109/LE
N0.01 – 0.10.1 x 109/LB
Low150 – 400<5 x 109/LPLT
N7.5-11.510.9 FLMPV
2- Peripheral blood smear
RBC morphology :-
Normocytic , normochromic
WBC morphology :-
Within normal limits
PLT morphology
Appear increased in size
Acute leukemia
(band cell)
Megaloblastic anemia
(macrocytic + pancytopenia)
Thrombotic thrombocytopenia purpura
(Schistocyte)
Investigation
Von willebrand’s disease type 2B
(PTT prolonged)
3- Further laboratory studies
Bone marrow biopsy
 Aspirate:
Erythrocyte and granulocyte maturation within normal limits. Megakaryocytes
appear increase in number and morphology
 Section:
hyprecellular , with abundant megakaryocytes .
 Coagulation
INR 0.91 (RI 0.85-1.15)
PTT 24.8 sec (RI 23-34)
TT 15.8 sec (RI 13-18)
Investigation
ITP
Idiopathic thrombocytopenia purpura
Differential diagnosis
ITP
What is ITP ?
Autoimmune (idiopathic) thrombocytopenic purpura (ITP) divided into chronic and acute
forms, and according to our case it is chronic idiopathic thrombocytopenic purpura.
The highest incidence has been considered to be in women aged 15-50 years although
some reports suggest an increasing incidence with age.
It is usually idiopathic but may be seen in association with other diseases such as :
Systemic Lupus Erythematosus (SLE), Human Immunodeficiency Virus (HIV), Chronic
Lymphocytic Leukemia (CLL), Hodgkin’s Disease.
pathogenesis
pathogenesis
ITP
purpura
petechiae
Hematoma
Epistaxis
Bleeding from the Gums
Hematuria
Heavy menstruation
clinical picture
With treatment, the chance of remission
(a symptom-free period) is good. In rare
cases, ITP may become a long-term
condition in adults and reappear, even
after a symptom-free period.
prognosis
ITP
Treatment
Treatments and drugs of ITP
“The goal of treating ITP is to ensure a safe
platelet count and prevent bleeding
complications while”treatment side
effects
Children:
About 80% of children with
ITP recover completely
within six months
Some children may need
treatment.
Adults:
-mild cases: require
regular monitoring and
platelet checks.
-sever cases: need
treatment.
Common initial medical treatments
Surgery
Platelet boosters
1st line treatment
2nd line treatment
3rd line treatment
Common initial medical treatments:
#Corticosteroids
1 to 2 mg/kg per day, given
as single or divided doses
increase platelet count
by the Decrease
activity of the immune
system.
Side effects high blood
sugar, (osteoporosis)
1st line treatment
Common initial medical treatments
#Intravenous
immune globulin
(IVIG)
1 g/kg per day for two days
Side effects:headache,
nausea and fever
#Anti-D Antibody
Splenectomy
2nd line treatment
-Rarely performed to children
-increases the susceptibility to
infections
Splenectomy:
-Thrombopoietin receptor agonists:
romiplostim (Nplate)
eltrombopag(Promacta).
3rd line treatment
Platelet boosters
it is binds to
thrombopoietin
receptor causes its
activation , stimulate
proliferation and
maturation of
megakaryocytes,
resulting in an
increase in circulating
platelet counts.
Platelet boosters
Treatments
Treatments
-Platelet transfusions (two platelet pools every 4-6
hours or platelet pool/h);
with/without
- IVIG (Privigen® 1 g/kg, repeated the following day
if the platelet count remains <50x109/L. Concurrent
use of IVIG increases platelet life span);
Emergency treatment:
with/without
- Intravenous methylprednisolone, 1 g/d for 3
days.

More Related Content

What's hot

Approach to thrombocytopenia.pptx
Approach to  thrombocytopenia.pptxApproach to  thrombocytopenia.pptx
Approach to thrombocytopenia.pptx
Pritish Chandra Patra
 
Thrombotic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic PurpuraThrombotic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic Purpura
Shakeel Arif
 

What's hot (20)

"ITP"
"ITP""ITP"
"ITP"
 
Approach to thrombocytopenia
Approach to thrombocytopeniaApproach to thrombocytopenia
Approach to thrombocytopenia
 
Hemolytic uremic syndrome
Hemolytic uremic syndrome Hemolytic uremic syndrome
Hemolytic uremic syndrome
 
Anemia of Chronic Disease
Anemia of Chronic DiseaseAnemia of Chronic Disease
Anemia of Chronic Disease
 
Hemolytic Uremic Syndrome: A Dangerous Complication of E. coli
Hemolytic Uremic Syndrome: A Dangerous Complication of E. coliHemolytic Uremic Syndrome: A Dangerous Complication of E. coli
Hemolytic Uremic Syndrome: A Dangerous Complication of E. coli
 
Aplastic anemia (aa)
Aplastic anemia  (aa)Aplastic anemia  (aa)
Aplastic anemia (aa)
 
TTP HUS
TTP HUSTTP HUS
TTP HUS
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Essential thrombocytosis
Essential thrombocytosisEssential thrombocytosis
Essential thrombocytosis
 
Immune thrombocytopenia
 Immune  thrombocytopenia Immune  thrombocytopenia
Immune thrombocytopenia
 
Bleeding disorder in pediatrics
Bleeding disorder in pediatricsBleeding disorder in pediatrics
Bleeding disorder in pediatrics
 
Approach to thrombocytopenia.pptx
Approach to  thrombocytopenia.pptxApproach to  thrombocytopenia.pptx
Approach to thrombocytopenia.pptx
 
Itp
ItpItp
Itp
 
Approach to thrombocytopenia
Approach to thrombocytopeniaApproach to thrombocytopenia
Approach to thrombocytopenia
 
Polycythemia: Causes, symptoms, diagnosis and treatment
Polycythemia: Causes, symptoms, diagnosis and treatmentPolycythemia: Causes, symptoms, diagnosis and treatment
Polycythemia: Causes, symptoms, diagnosis and treatment
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Paroxysmal nocturnal hematuria
Paroxysmal nocturnal hematuriaParoxysmal nocturnal hematuria
Paroxysmal nocturnal hematuria
 
Hemolytic uremic Syndrome
Hemolytic uremic SyndromeHemolytic uremic Syndrome
Hemolytic uremic Syndrome
 
Thrombotic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic PurpuraThrombotic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic Purpura
 
Systemic lupus erythematosis
Systemic lupus erythematosis Systemic lupus erythematosis
Systemic lupus erythematosis
 

Similar to Idiopathic thrombocytopenic purpura

hemolytic-uremicsyndrome-121116000313-phpapp01.pdf
hemolytic-uremicsyndrome-121116000313-phpapp01.pdfhemolytic-uremicsyndrome-121116000313-phpapp01.pdf
hemolytic-uremicsyndrome-121116000313-phpapp01.pdf
drmanzoor234
 
Hemolytic uremic syndrome
Hemolytic uremic syndromeHemolytic uremic syndrome
Hemolytic uremic syndrome
Najib Suhrabi
 
Idiopathic thrombocytopenic Purpura
Idiopathic thrombocytopenic PurpuraIdiopathic thrombocytopenic Purpura
Idiopathic thrombocytopenic Purpura
DrRamkumarP
 
Accerlerated hypertension
Accerlerated hypertensionAccerlerated hypertension
Accerlerated hypertension
Sachin Verma
 
An understanding of the factors surrounding women’s and men’s he.docx
An understanding of the factors surrounding women’s and men’s he.docxAn understanding of the factors surrounding women’s and men’s he.docx
An understanding of the factors surrounding women’s and men’s he.docx
SHIVA101531
 

Similar to Idiopathic thrombocytopenic purpura (20)

Immune Thrombocytopenic Purpura
Immune Thrombocytopenic PurpuraImmune Thrombocytopenic Purpura
Immune Thrombocytopenic Purpura
 
Hemolytic uremicsyndrome-121116000313-phpapp01
Hemolytic uremicsyndrome-121116000313-phpapp01Hemolytic uremicsyndrome-121116000313-phpapp01
Hemolytic uremicsyndrome-121116000313-phpapp01
 
Immune Thrombocytopenia (ITP).pdf
Immune Thrombocytopenia (ITP).pdfImmune Thrombocytopenia (ITP).pdf
Immune Thrombocytopenia (ITP).pdf
 
Haem
HaemHaem
Haem
 
Mr 2.24.14
Mr 2.24.14Mr 2.24.14
Mr 2.24.14
 
hemolytic-uremicsyndrome-121116000313-phpapp01.pdf
hemolytic-uremicsyndrome-121116000313-phpapp01.pdfhemolytic-uremicsyndrome-121116000313-phpapp01.pdf
hemolytic-uremicsyndrome-121116000313-phpapp01.pdf
 
Hemolytic uremic syndrome
Hemolytic uremic syndromeHemolytic uremic syndrome
Hemolytic uremic syndrome
 
Itp in pregnancy
Itp in pregnancyItp in pregnancy
Itp in pregnancy
 
ITP
ITPITP
ITP
 
Hyperviscosity syndrome CPC
 Hyperviscosity syndrome CPC Hyperviscosity syndrome CPC
Hyperviscosity syndrome CPC
 
Idiopathic thrombocytopenic Purpura
Idiopathic thrombocytopenic PurpuraIdiopathic thrombocytopenic Purpura
Idiopathic thrombocytopenic Purpura
 
SYSTEMIC LUPUS ERYTHEMATOSUS.pptx
SYSTEMIC LUPUS ERYTHEMATOSUS.pptxSYSTEMIC LUPUS ERYTHEMATOSUS.pptx
SYSTEMIC LUPUS ERYTHEMATOSUS.pptx
 
‏‏‏‏ALAWLAQI-FINAL HTN ADJUSTED.pptx
‏‏‏‏ALAWLAQI-FINAL HTN ADJUSTED.pptx‏‏‏‏ALAWLAQI-FINAL HTN ADJUSTED.pptx
‏‏‏‏ALAWLAQI-FINAL HTN ADJUSTED.pptx
 
Sle by dr qudsia
Sle by dr qudsiaSle by dr qudsia
Sle by dr qudsia
 
Itp
ItpItp
Itp
 
Accerlerated hypertension
Accerlerated hypertensionAccerlerated hypertension
Accerlerated hypertension
 
An understanding of the factors surrounding women’s and men’s he.docx
An understanding of the factors surrounding women’s and men’s he.docxAn understanding of the factors surrounding women’s and men’s he.docx
An understanding of the factors surrounding women’s and men’s he.docx
 
Updates on sepsis & septic shock
Updates on sepsis & septic shockUpdates on sepsis & septic shock
Updates on sepsis & septic shock
 
approach to sick neonate.pptx
approach to sick neonate.pptxapproach to sick neonate.pptx
approach to sick neonate.pptx
 
Anaemia
AnaemiaAnaemia
Anaemia
 

Recently uploaded

Recently uploaded (20)

Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
Plant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptxPlant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptx
 
Philosophy of china and it's charactistics
Philosophy of china and it's charactisticsPhilosophy of china and it's charactistics
Philosophy of china and it's charactistics
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 

Idiopathic thrombocytopenic purpura

  • 1.
  • 2. ITP
  • 3. 60-year-old female Presented in emergency room with recent onset of easy bruising, bleeding gums, and persistent epistaxis .She has no personal or family history of a bleeding disorder and takes no medicines. Case scenario
  • 4. History Age: 60 year old Gander: Female Occupation: Don’t work Personal history recent onset of easy bruising bleeding gums and persistent epistaxis Chief complain
  • 6. No previous similar conditionPast history No significant family history or bleeding disorder were reported Social and family history History
  • 7. ITP
  • 9. Local examination  easy bruising  bleeding gums  Persistent epistaxis  Abdominal examination reveled no hepatosplenomegaly  No abdominal tenderness Physical examination
  • 10. Physical examination Local examination  Examination of the skin Numerous petechiae and purpura mostly on the extremities  Joint were non tender and non erythematous  The neurologic examination was normal
  • 11. ITP
  • 12. Differential diagnosis Aplastic anemia Acute leukemia Idiopathic thrombocytopenia purpura Myelodysplastic syndrome Megaloblastic anemia Von willebrand’s disease Thrombotic thrombocytopenia purpura
  • 13. ITP
  • 14. 1- CBC 2- Peripheral blood smear 3- Further investigations - bone marrow biopsy - coagulation Investigation
  • 15. 1- CBC  Aplastic anemia (pancytopenia)  Myelodysplastic syndrome (pancytopenia and splenomegaly )  Von willebrand’s disease (platelets count normal except 2B) Investigation FlagsReference rangeResultTest N3.8 – 4.84.52 x 1012/LRBC N12 – 1513.4 g/ dLHGB Low38 – 4837.2 %HCT low83 – 10182.3 FLMCV N27 – 3229.6 pgMCH High31.5 – 34.535.9 g/dLMCHC N11.6 – 1412.1 %RDW N4 – 115.3 x 109/LWBC N2.5 – 7.52.3 x 109/LN N1.5 – 3.52.1 x 109/LL N0.2 – 0.80.7 x 109/LM N0.04 – 0.40.1 x 109/LE N0.01 – 0.10.1 x 109/LB Low150 – 400<5 x 109/LPLT N7.5-11.510.9 FLMPV
  • 16. 2- Peripheral blood smear RBC morphology :- Normocytic , normochromic WBC morphology :- Within normal limits PLT morphology Appear increased in size Acute leukemia (band cell) Megaloblastic anemia (macrocytic + pancytopenia) Thrombotic thrombocytopenia purpura (Schistocyte) Investigation
  • 17. Von willebrand’s disease type 2B (PTT prolonged) 3- Further laboratory studies Bone marrow biopsy  Aspirate: Erythrocyte and granulocyte maturation within normal limits. Megakaryocytes appear increase in number and morphology  Section: hyprecellular , with abundant megakaryocytes .  Coagulation INR 0.91 (RI 0.85-1.15) PTT 24.8 sec (RI 23-34) TT 15.8 sec (RI 13-18) Investigation
  • 18. ITP
  • 20. ITP
  • 21. What is ITP ? Autoimmune (idiopathic) thrombocytopenic purpura (ITP) divided into chronic and acute forms, and according to our case it is chronic idiopathic thrombocytopenic purpura. The highest incidence has been considered to be in women aged 15-50 years although some reports suggest an increasing incidence with age. It is usually idiopathic but may be seen in association with other diseases such as : Systemic Lupus Erythematosus (SLE), Human Immunodeficiency Virus (HIV), Chronic Lymphocytic Leukemia (CLL), Hodgkin’s Disease. pathogenesis
  • 23. ITP
  • 24. purpura petechiae Hematoma Epistaxis Bleeding from the Gums Hematuria Heavy menstruation clinical picture
  • 25. With treatment, the chance of remission (a symptom-free period) is good. In rare cases, ITP may become a long-term condition in adults and reappear, even after a symptom-free period. prognosis
  • 26. ITP
  • 28. Treatments and drugs of ITP “The goal of treating ITP is to ensure a safe platelet count and prevent bleeding complications while”treatment side effects
  • 29. Children: About 80% of children with ITP recover completely within six months Some children may need treatment. Adults: -mild cases: require regular monitoring and platelet checks. -sever cases: need treatment.
  • 30. Common initial medical treatments Surgery Platelet boosters 1st line treatment 2nd line treatment 3rd line treatment
  • 31. Common initial medical treatments: #Corticosteroids 1 to 2 mg/kg per day, given as single or divided doses increase platelet count by the Decrease activity of the immune system. Side effects high blood sugar, (osteoporosis) 1st line treatment Common initial medical treatments #Intravenous immune globulin (IVIG) 1 g/kg per day for two days Side effects:headache, nausea and fever #Anti-D Antibody
  • 32. Splenectomy 2nd line treatment -Rarely performed to children -increases the susceptibility to infections Splenectomy:
  • 33. -Thrombopoietin receptor agonists: romiplostim (Nplate) eltrombopag(Promacta). 3rd line treatment Platelet boosters it is binds to thrombopoietin receptor causes its activation , stimulate proliferation and maturation of megakaryocytes, resulting in an increase in circulating platelet counts. Platelet boosters
  • 34. Treatments Treatments -Platelet transfusions (two platelet pools every 4-6 hours or platelet pool/h); with/without - IVIG (Privigen® 1 g/kg, repeated the following day if the platelet count remains <50x109/L. Concurrent use of IVIG increases platelet life span); Emergency treatment: with/without - Intravenous methylprednisolone, 1 g/d for 3 days.

Editor's Notes

  1. Constitutional symptoms:- the patient who has ( fever +night sweating + loss of weight + loss of appetite + fatigability ) these symptoms should be asked Specifically about with most complaints
  2. Blood pressure was normal heart rate was normal temperature 37 c˚ respiratory rate 18 breaths/min
  3. Diagnostic Tests You'll likely have blood tests to check your platelet count. These tests usually include: A complete blood count. This test checks the number of red blood cells, white blood cells, and platelets in your blood. In ITP, the red and white blood cell counts are normal, but the platelet count is low. A blood smear. For this test, some of your blood is put on a slide. A microscope is used to look at your platelets and other blood cells. You also may have a blood test to check for the antibodies (proteins) that attack platelets. If blood tests show that your platelet count is low, your doctor may recommend more tests to confirm a diagnosis of ITP. For example, bone marrow tests can show whether your bone marrow is making enough platelets.
  4. On complete blood cell count: The workup for immune thrombocytopenic purpura (ITP) starts with a complete blood cell (CBC) count. The hallmark of ITP is isolated thrombocytopenia Aplastic anemia (In aplastic anemia there is pancytopenia) Myelodysplastic syndrome (In myelodysplastic syndrome there is pancytopenia and splenomegaly ) Von willebrand’s disease (the problem in von willebrand’s disease is not the platelets so all type of this disease show normal PLT count except type 2B which show thrombocytopenia)
  5. Findings on peripheral blood smear of patient with ITP are as follows The morphology of red blood cells (RBCs) and leukocytes is normal The morphology of platelets is typically normal, with varying numbers of large platelets If most of the platelets are large, approximating the diameter of red blood cells, or if they lack granules or have an abnormal color, consider an inherited platelet disorder Acute leukemia (in Acute leukemia band cell appear in peripheral blood smear) Megaloblastic anemia (IN Megaloblastic anemia there is macrocytic RBC + pancytopenia) Thrombotic thrombocytopenia purpura (In Thrombotic thrombocytopenia purpura peripheral blood smear Schistocyte)
  6. If you have ITP, your bone marrow will be normal because your low platelet count is caused by the destruction of platelets in your bloodstream and spleen — not by a problem with the bone marrow. Bone marrow aspiration and biopsy in patients with immune thrombocytopenic purpura (ITP) demonstrates a normal-to-increased number of megakaryocytes in the absence of other significant abnormalities. In adults who are thrombocytopenic and older than 60 years, we examine the bone marrow to exclude myelodysplastic syndrome or leukemia Aspects of bone marrow aspiration and biopsy are as follows: Biopsy in patients with ITP shows a increased number of megakaryocytes in the absence of other significant abnormalities Bone marrow aspirate The cellularity of the aspirate and the morphology of erythroid and myeloid precursors should be normal. The number of megakaryocytes may be increased. Because the peripheral destruction of platelets is increased, megakaryocytes may be large and immature, although in many cases the megakaryocyte morphology is normal. Older patients require a careful examination of megakaryocyte morphology to exclude an early myelodysplastic syndrome. Bone marrow biopsy Sections of a needle biopsy specimen or marrow clot should reveal normal marrow cellularity, without evidence of hypoplasia or increased fibrosis. Von willebrand’s disease type 2B ( In this type there is thrombocytopenia and prolonged PTT)
  7. Antibody is formed against GP ( glycoprotein ) IIb / IIIa “ in most cases “ or Ib , antigen on platelet. Then Antibody is attached to Antigen on platelet surface ( Sensitized platelet ) , After that it is engulfed by Spleen Machrophage.
  8. With treatment, the chance of remission (a symptom-free period) is good. In rare cases, ITP may become a long-term condition in adults and reappear, even after a symptom-free period.